Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 4 hrs 35 mins

S&P Futures
5,968.50
+10.25(+0.17%)
Dow Futures
43,966.00
+65.00(+0.15%)
Nasdaq Futures
20,943.50
+49.50(+0.24%)
Russell 2000 Futures
2,412.70
+6.90(+0.29%)
Crude Oil
71.21
-0.48(-0.67%)
Gold
2,670.40
-5.90(-0.22%)

Cytokinetics, Incorporated (CYTK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

55.50

+2.98

(+5.67%)

At close: 04:00PM EST

53.20

-2.30

(-4.14%)

After hours:

07:46PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	6.53B
Enterprise Value	6.26B
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	1.80k
Price/Book (mrq)	60.16
Enterprise Value/Revenue	2.00k
Enterprise Value/EBITDA	-15.82

Trading Information

Stock Price History

Beta (5Y Monthly)	0.77
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	110.25
52 Week Low ³	30.68
50-Day Moving Average ³	54.09
200-Day Moving Average ³	61.15

Share Statistics

Avg Vol (3 month) ³	1.15M
Avg Vol (10 day) ³	850.21k
Shares Outstanding ⁵	117.66M
Implied Shares Outstanding ⁶	N/A
Float ⁸	117.06M
% Held by Insiders ¹	0.50%
% Held by Institutions ¹	118.31%
Shares Short (Oct 15, 2024) ⁴	15.54M
Short Ratio (Oct 15, 2024) ⁴	12.11
Short % of Float (Oct 15, 2024) ⁴	20.18%
Short % of Shares Outstanding (Oct 15, 2024) ⁴	13.21%
Shares Short (prior month Sep 13, 2024) ⁴	17.84M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:6
Last Split Date ³	Jun 25, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-52,277.91%

Management Effectiveness

Return on Assets (ttm)	-27.46%
Return on Equity (ttm)	N/A

Income Statement

Revenue (ttm)	3.13M
Revenue Per Share (ttm)	0.03
Quarterly Revenue Growth (yoy)	-71.30%
Gross Profit (ttm)	N/A
EBITDA	-493.16M
Net Income Avi to Common (ttm)	-545.28M
Diluted EPS (ttm)	-5.36
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	1.06B
Total Cash Per Share (mrq)	8.98
Total Debt (mrq)	790.18M
Total Debt/Equity (mrq)	727.94
Current Ratio (mrq)	10.39
Book Value Per Share (mrq)	0.92

Cash Flow Statement

Operating Cash Flow (ttm)	-399.06M
Levered Free Cash Flow (ttm)	-233.93M